DK0626961T3 - Fremgangsmåde til nitrosering - Google Patents

Fremgangsmåde til nitrosering

Info

Publication number
DK0626961T3
DK0626961T3 DK93903271T DK93903271T DK0626961T3 DK 0626961 T3 DK0626961 T3 DK 0626961T3 DK 93903271 T DK93903271 T DK 93903271T DK 93903271 T DK93903271 T DK 93903271T DK 0626961 T3 DK0626961 T3 DK 0626961T3
Authority
DK
Denmark
Prior art keywords
formula
compounds
nitrosation
chem
nitrosating
Prior art date
Application number
DK93903271T
Other languages
English (en)
Inventor
Mark Jason Hughes
John Kitteringham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0626961T3 publication Critical patent/DK0626961T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93903271T 1992-02-20 1993-02-11 Fremgangsmåde til nitrosering DK0626961T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process
PCT/GB1993/000291 WO1993017018A1 (en) 1992-02-20 1993-02-11 Nitrosation process

Publications (1)

Publication Number Publication Date
DK0626961T3 true DK0626961T3 (da) 2000-11-06

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93903271T DK0626961T3 (da) 1992-02-20 1993-02-11 Fremgangsmåde til nitrosering

Country Status (19)

Country Link
US (2) US5545740A (da)
EP (2) EP0626961B1 (da)
JP (1) JP3288704B2 (da)
KR (1) KR100261530B1 (da)
AT (1) ATE194341T1 (da)
AU (1) AU669355B2 (da)
CA (1) CA2131019C (da)
DE (1) DE69328962T2 (da)
DK (1) DK0626961T3 (da)
ES (1) ES2147749T3 (da)
GB (1) GB9203688D0 (da)
GR (1) GR3034295T3 (da)
HK (1) HK1012366A1 (da)
MX (1) MX9300875A (da)
NZ (1) NZ246940A (da)
PT (1) PT626961E (da)
TW (1) TW224466B (da)
WO (1) WO1993017018A1 (da)
ZA (1) ZA931132B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
EP1007041A4 (en) * 1997-04-11 2001-03-07 Lilly Co Eli COMPOSITION FOR TREATING PAIN
US6284771B1 (en) * 1997-04-11 2001-09-04 Eli Lilly And Company Method for treating schizophrenia
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2275095A3 (en) * 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
ATE194341T1 (de) 2000-07-15
KR950700292A (ko) 1995-01-16
WO1993017018A1 (en) 1993-09-02
JPH07504180A (ja) 1995-05-11
EP0984008A3 (en) 2000-05-03
GB9203688D0 (en) 1992-04-08
ZA931132B (en) 1993-10-14
AU3460793A (en) 1993-09-13
EP0626961B1 (en) 2000-07-05
PT626961E (pt) 2000-10-31
AU669355B2 (en) 1996-06-06
GR3034295T3 (en) 2000-12-29
ES2147749T3 (es) 2000-10-01
DE69328962T2 (de) 2000-12-28
US5545740A (en) 1996-08-13
US20020143185A1 (en) 2002-10-03
HK1012366A1 (en) 1999-07-30
JP3288704B2 (ja) 2002-06-04
CA2131019C (en) 2002-12-24
EP0984008A2 (en) 2000-03-08
US6596869B2 (en) 2003-07-22
DE69328962D1 (de) 2000-08-10
MX9300875A (es) 1993-08-31
TW224466B (da) 1994-06-01
NZ246940A (en) 1996-06-25
KR100261530B1 (ko) 2000-08-01
EP0626961A1 (en) 1994-12-07
CA2131019A1 (en) 1993-08-21

Similar Documents

Publication Publication Date Title
DK0626961T3 (da) Fremgangsmåde til nitrosering
FI931888A (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
DE69027440T2 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
EP0742209A3 (en) Process for the preparation of an optically active quinoline demevalonolacton and process for the preparation of a salt of an optically active quinoline demevalolon
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
NO932232D0 (no) Organiske cerium (iv)-forbindelser, deres fremstilling oganvendelse
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
DK154837C (da) Oxadiazolylimidazobenzodiazepinforbindelse og farmaceutisk praeparat indeholdende samme
NO933199D0 (no) Heteroarenylpiperaziner, fremgangsm}te for deres fremstilling og anvendelse derav som legemidler
CA2193310A1 (fr) Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui les contiennent
PT92355A (pt) Processo para a preparacao de derivados de di-hidro-piridina
ATE78489T1 (de) Kristallinische n-(s-3-methylheptanoyl)-d-gammaglutamyl-glycyl-d-alanine und deren verfahren und zwischenverbindungen.
DK162188A (da) Fremgangsmaade til fremstilling af pentandionderivater
ATE92481T1 (de) Verfahren zur herstellung von n,n'-bis-(2hydroxyethyl)-piperazin.
TH13944EX (th) สารประกอบเฮเทโรไซคลิค